![]()
29.07.20151497
Beta-blocker therapy is one of the most commonly prescribed treatments for patients with cardiac conditions. In patients with out-of-hospital cardiac arrest (OHCA) however, recent data suggest prior treatment with beta-blockers could be harmful by lowering the incidence of a shockable presenting rhythm.
![]()
27.07.20151766
Women with Fontan circulation can successfully complete pregnancy, but an increase in cardiac and neonatal morbidity exists, results by French researchers published in the International Journal of Cardiology show.
![]()
24.07.20151565
The FDA and Sanofi/Regeneron announced that the agency has approved alirocumab, a PCSK9 inhibitor, for lowering of LDL in addition to diet and maximally tolerated statin therapy in patients with heterozygous familial hypercholesterolemia or those with clinical atherosclerotic CVD.
![]()
23.07.20151416
Dislipidemia in type 2 diabetes mellitus contributes to arterial endothelial dysfunction and an increased risk of cardiovascular disease.
![]()
22.07.20151591
The drug, to be marketed as Repatha (Amgen), is the first PCSK9 inhibitor to be approved for intensive reduction of LDL, according to a company press release.
![]()
21.07.20151565
Patients with psoriasis, and particularly those with psoriatic arthritis, were at increased risk of developing arrhythmia, independent of traditional cardiovascular risk factors, according to recently published study results.
![]()
21.07.20151534
To participate in the expertise scientist has to be registered in the Science Index as author of scientific articles, an academic degree and total number of citations for 5 years (2009-2013) not less than fixed (different for each research field).
